NZ514248A - Pharmaceutical composition in a unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate - Google Patents
Pharmaceutical composition in a unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphateInfo
- Publication number
- NZ514248A NZ514248A NZ514248A NZ51424800A NZ514248A NZ 514248 A NZ514248 A NZ 514248A NZ 514248 A NZ514248 A NZ 514248A NZ 51424800 A NZ51424800 A NZ 51424800A NZ 514248 A NZ514248 A NZ 514248A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutical composition
- unit form
- acid
- acetylsalcylic
- form containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
A pharmaceutical composition contains in galenical unit form the active principles acetylsalicylic acid and clopidogrel hydrogenosulphonate. The composition is useful treating pathology induced by for platelet aggregation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9905497A FR2792836B3 (en) | 1999-04-30 | 1999-04-30 | PHARMACEUTICAL COMPOSITION IN UNIT FORM CONTAINING ASPIRIN AND CLOPIDOGREL HYDROGENOSULFATE |
PCT/FR2000/001086 WO2000066130A1 (en) | 1999-04-30 | 2000-04-25 | Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ514248A true NZ514248A (en) | 2003-06-30 |
Family
ID=9545071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ514248A NZ514248A (en) | 1999-04-30 | 2000-04-25 | Pharmaceutical composition in a unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1178809A1 (en) |
JP (1) | JP2002543137A (en) |
KR (1) | KR20020005735A (en) |
CN (1) | CN1359294A (en) |
AR (1) | AR023789A1 (en) |
AU (1) | AU4303600A (en) |
BR (1) | BR0010194A (en) |
CA (1) | CA2371231A1 (en) |
CZ (1) | CZ20013887A3 (en) |
EA (1) | EA200100959A1 (en) |
EE (1) | EE200100559A (en) |
FR (1) | FR2792836B3 (en) |
HK (1) | HK1041823A1 (en) |
HU (1) | HUP0202329A2 (en) |
IL (1) | IL145648A0 (en) |
IS (1) | IS6084A (en) |
MX (1) | MXPA01011071A (en) |
NO (1) | NO20015295L (en) |
NZ (1) | NZ514248A (en) |
PL (1) | PL351923A1 (en) |
SK (1) | SK15542001A3 (en) |
TR (1) | TR200103039T2 (en) |
UY (1) | UY26131A1 (en) |
WO (1) | WO2000066130A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60135780D1 (en) | 2000-12-25 | 2008-10-23 | Daiichi Sankyo Co Ltd | ASPIRIN-CONTAINING MEDICAL COMPOSITIONS |
US6767913B2 (en) | 2001-12-18 | 2004-07-27 | Teva Pharmaceutical Industries Ltd. | Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms |
US7074928B2 (en) | 2002-01-11 | 2006-07-11 | Teva Pharmaceutical Industries, Ltd. | Polymorphs of clopidogrel hydrogensulfate |
US6800759B2 (en) | 2002-08-02 | 2004-10-05 | Teva Pharmaceutical Industries Ltd. | Racemization and enantiomer separation of clopidogrel |
IL166593A0 (en) | 2002-08-02 | 2006-01-15 | Racemization and enantiomer separation of clopidogrel | |
JP4917255B2 (en) * | 2003-10-16 | 2012-04-18 | 第一三共ヘルスケア株式会社 | Oral composition containing salicylic acids |
WO2005070464A2 (en) * | 2004-01-21 | 2005-08-04 | Biofarma Ilac Sanayi Ve Ticaret A.S. | A tablet formulation of clopidogrel bisulphate |
JP2008543843A (en) * | 2005-06-13 | 2008-12-04 | エラン ファーマ インターナショナル リミテッド | Combination preparation of nanoparticulate clopidogrel and aspirin |
KR20070009851A (en) * | 2005-07-14 | 2007-01-19 | 씨제이 주식회사 | Pharmaceutical compositions containing clopidogrel bisulfate |
KR100736024B1 (en) * | 2005-09-21 | 2007-07-06 | 주식회사종근당 | Novel resinate complex of S-clopidogrel and production method thereof |
KR20070044323A (en) * | 2005-10-24 | 2007-04-27 | 에스케이케미칼주식회사 | Stabilized pharmaceutical oral preparation containing clopidogrel bisulfate |
US20100145053A1 (en) * | 2006-04-05 | 2010-06-10 | Cadila Healthcare Limited | Modified release clopidogrel formulation |
EP1900358A1 (en) * | 2006-09-16 | 2008-03-19 | Cimex Pharma AG | Pharmaceutical formulations comprising clopidogrel |
HUP0600839A3 (en) * | 2006-11-14 | 2008-09-29 | Egis Gyogyszergyar Nyrt | Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof |
EP2255797A4 (en) * | 2008-02-22 | 2011-09-07 | Hanall Biopharma Co Ltd | Composite preparation |
CN101695496A (en) * | 2009-10-15 | 2010-04-21 | 苏春华 | Medicinal composition containing triflusal and clopidogrel |
JP2013032289A (en) * | 2009-10-28 | 2013-02-14 | Daiichi Sankyo Co Ltd | Wax stable formulation |
RU2484820C2 (en) * | 2011-02-24 | 2013-06-20 | Общество с ограниченной ответственностью "Озон" | Combined medicine as thrombocyte aggregation inhibitor |
KR101675501B1 (en) | 2011-11-02 | 2016-11-14 | 한국유나이티드제약 주식회사 | Combination of Clopidogrel and Aspirin |
CN102406938A (en) * | 2011-11-29 | 2012-04-11 | 北京阜康仁生物制药科技有限公司 | Medicine composition for resisting thrombosis |
JP6004524B2 (en) * | 2012-07-11 | 2016-10-12 | 大原薬品工業株式会社 | Method for producing clopidogrel sulfate-containing tablets |
JP5905165B2 (en) * | 2013-08-02 | 2016-04-20 | サノフイ | Pharmaceutical tablets containing acetylsalicylic acid and clopidogrel |
CN104434932B (en) * | 2014-12-18 | 2017-05-24 | 成都苑东生物制药股份有限公司 | Pharmaceutical composition of clopidogrel hydrogen sulfate and acetylsalicylic acid tablet and preparation method thereof |
WO2017037741A1 (en) * | 2015-09-02 | 2017-03-09 | Sun Pharmaceutical Industries Ltd | Compact solid dosage form of aspirin and clopidogrel |
CN115737578A (en) * | 2022-11-23 | 2023-03-07 | 石家庄四药有限公司 | Clopidogrel hydrogen sulfate and aspirin compound tablet and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2623810B2 (en) | 1987-02-17 | 1992-01-24 | Sanofi Sa | ALPHA SALTS- (TETRAHYDRO-4,5,6,7 THIENO (3,2-C) PYRIDYL-5) (2-CHLORO-PHENYL) -THETHYL ACETATE DEXTROGYRE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
US5576328A (en) * | 1994-01-31 | 1996-11-19 | Elf Sanofi | Method for the secondary prevention of ischemic events |
FR2744918B1 (en) | 1996-02-19 | 1998-05-07 | Sanofi Sa | NEW COMBINATIONS OF ACTIVE INGREDIENTS CONTAINING THIENO (3,2-C) PYRIDINE DERIVATIVE AND AN ANTITHROMBOTIC |
FR2779726B1 (en) | 1998-06-15 | 2001-05-18 | Sanofi Sa | POLYMORPHIC FORM OF CLOPIDOGREL HYDROGENOSULFATE |
-
1999
- 1999-04-30 FR FR9905497A patent/FR2792836B3/en not_active Expired - Fee Related
-
2000
- 2000-04-25 MX MXPA01011071A patent/MXPA01011071A/en unknown
- 2000-04-25 EE EEP200100559A patent/EE200100559A/en unknown
- 2000-04-25 CA CA002371231A patent/CA2371231A1/en not_active Abandoned
- 2000-04-25 NZ NZ514248A patent/NZ514248A/en unknown
- 2000-04-25 IL IL14564800A patent/IL145648A0/en unknown
- 2000-04-25 SK SK1554-2001A patent/SK15542001A3/en unknown
- 2000-04-25 EP EP00922737A patent/EP1178809A1/en not_active Withdrawn
- 2000-04-25 CZ CZ20013887A patent/CZ20013887A3/en unknown
- 2000-04-25 HU HU0202329A patent/HUP0202329A2/en unknown
- 2000-04-25 BR BR0010194-0A patent/BR0010194A/en not_active Application Discontinuation
- 2000-04-25 JP JP2000615014A patent/JP2002543137A/en not_active Withdrawn
- 2000-04-25 CN CN00807001A patent/CN1359294A/en active Pending
- 2000-04-25 AU AU43036/00A patent/AU4303600A/en not_active Abandoned
- 2000-04-25 TR TR2001/03039T patent/TR200103039T2/en unknown
- 2000-04-25 KR KR1020017013830A patent/KR20020005735A/en not_active Application Discontinuation
- 2000-04-25 WO PCT/FR2000/001086 patent/WO2000066130A1/en not_active Application Discontinuation
- 2000-04-25 EA EA200100959A patent/EA200100959A1/en unknown
- 2000-04-25 PL PL00351923A patent/PL351923A1/en not_active Application Discontinuation
- 2000-04-28 AR ARP000102020A patent/AR023789A1/en unknown
- 2000-04-28 UY UY26131A patent/UY26131A1/en not_active Application Discontinuation
-
2001
- 2001-09-25 IS IS6084A patent/IS6084A/en unknown
- 2001-10-29 NO NO20015295A patent/NO20015295L/en not_active Application Discontinuation
-
2002
- 2002-05-14 HK HK02103639.9A patent/HK1041823A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1178809A1 (en) | 2002-02-13 |
TR200103039T2 (en) | 2002-01-21 |
CA2371231A1 (en) | 2000-11-09 |
HK1041823A1 (en) | 2002-07-26 |
EA200100959A1 (en) | 2002-06-27 |
SK15542001A3 (en) | 2002-02-05 |
NO20015295L (en) | 2001-12-21 |
MXPA01011071A (en) | 2002-07-22 |
AR023789A1 (en) | 2002-09-04 |
UY26131A1 (en) | 2000-12-29 |
EE200100559A (en) | 2003-02-17 |
AU4303600A (en) | 2000-11-17 |
IS6084A (en) | 2001-09-25 |
FR2792836B3 (en) | 2001-07-27 |
BR0010194A (en) | 2002-02-13 |
NO20015295D0 (en) | 2001-10-29 |
HUP0202329A2 (en) | 2002-10-28 |
PL351923A1 (en) | 2003-06-30 |
CN1359294A (en) | 2002-07-17 |
WO2000066130A1 (en) | 2000-11-09 |
CZ20013887A3 (en) | 2002-02-13 |
FR2792836A1 (en) | 2000-11-03 |
IL145648A0 (en) | 2002-06-30 |
JP2002543137A (en) | 2002-12-17 |
KR20020005735A (en) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ514248A (en) | Pharmaceutical composition in a unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate | |
CA2395331A1 (en) | Pharmaceutical compositions providing enhanced drug concentrations | |
PT768867E (en) | DOSAGE FORM FOR THE ADMINISTRATION OF DRUG IN LIQUID FORMULATION | |
HK1060566A1 (en) | Anticholinergic agents that can be used as medicaments and method for the production thereof | |
ES2176684T3 (en) | NEW ASSOCIATIONS OF ACTIVE PRINCIPLES CONTAINING CLOPIDOGREL AND AN ANTHROMBOTIC. | |
HUP0200831A2 (en) | Novel pharmaceutical composition containing amoxycillin and its use | |
PT1183029E (en) | PHARMACEUTICAL PREPARATION CONTAINING THE ACTIVE DIAMORPHINE PRINCIPLE AND ITS USE IN A PROCESS FOR THE TREATMENT OF OPIACEAL DEPENDENCE | |
HUP0204071A3 (en) | Nitrogenous cyclic compounds and pharmaceutical compositions containing the same and their use | |
HUP0204373A3 (en) | Carboxylic acid amides, pharmaceutical compositions containing these compounds and the use and production thereof | |
ES2113636T3 (en) | SUBSTITUTED TRIOLS. | |
HK1038508A1 (en) | Dosage form comprising liquid formulation | |
IL140685A0 (en) | Nitric esters and nitrate salts of specific drugs | |
ITMI931014A0 (en) | SLOW-RELEASE PHARMACEUTICAL COMPOSITION CONTAINING A BILE ACID AS THE ACTIVE SUBSTANCE | |
IS6654A (en) | Stable gabapentin with pH within the controlled range | |
CZ10095A3 (en) | Tablet with enhanced biological access of clodronic acid active component, packaging of such tablets and the use of the active component for the preparation of the tablets and process of producing such tablets | |
CA2436511A1 (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
IL151197A0 (en) | Thiazepinyl hydroxamic acid derivatives and pharmaceutical compositions containing the same | |
AR030648A1 (en) | PHARMACEUTICAL COMPOSITION WITH MODIFIED EXCIPIENT | |
ES8205394A1 (en) | Treatment of shock | |
AR030647A1 (en) | PHARMACEUTICAL COMPOSITION WITH SPECIFIC WATER ACTIVITY | |
ITMI932193A0 (en) | COMPOUNDS WITH ANTIHISTAMINIC ACTIVITY FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
AU6553900A (en) | Water-soluble cephalomannine esters with poly-amino-acid or the salts thereof, pharmaceutical compositions containing them and their use in medicine | |
WO2001091733A3 (en) | Combination of active substances containing montirelin and a compound having an opioid effect | |
PL343988A1 (en) | Pharmacological composition containing active substances in the form of their solution | |
ITMI920273U1 (en) | VAGINAL CANNULA FOR THE APPLICATION OF TABLET PRODUCTS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed |